Evidence map›Paper›PMID 36739297›Full record

ArticleScientific reports2023

Absolute dosimetry for FLASH proton pencil beam scanning radiotherapy.

Ana Lourenço, Anna Subiel, Nigel Lee, Sam Flynn, John Cotterill, David Shipley, Francesco Romano, Joe Speth, Eunsin Lee, Yongbin Zhang and 5 more

Abstract read
In one paragraph

Article in Scientific reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Democratizing FLASH Radiotherapy.Seminars in radiation oncology · 2024
    Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Ana LourençoNational Physical Laboratory, Teddington, TW11 0LW, UK. ana.lourenco@npl.co.uk.
Anna SubielNational Physical Laboratory, Teddington, TW11 0LW, UK.
Nigel LeeNational Physical Laboratory, Teddington, TW11 0LW, UK.
Sam FlynnNational Physical Laboratory, Teddington, TW11 0LW, UK.
John CotterillNational Physical Laboratory, Teddington, TW11 0LW, UK.
David ShipleyNational Physical Laboratory, Teddington, TW11 0LW, UK.
Francesco RomanoIstituto Nazionale di Fisica Nucleare, Sezione di Catania, Via S Sofia 64, 95123, Catania, Italy.
Joe SpethCincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
Eunsin LeeCincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
Yongbin ZhangCincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
Zhiyan XiaoCincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
Anthony MasciaCincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
Richard A AmosUniversity College London, London, WC1E 6BT, UK.
Hugo PalmansNational Physical Laboratory, Teddington, TW11 0LW, UK.
Russell ThomasNational Physical Laboratory, Teddington, TW11 0LW, UK.

Funding

Cancer Research UK A21993
6 · The paper itself

Abstract

A paradigm shift is occurring in clinical oncology exploiting the recent discovery that short pulses of ultra-high dose rate (UHDR) radiation-FLASH radiotherapy-can significantly spare healthy tissues whilst still being at least as effective in curing cancer as radiotherapy at conventional dose rates. These properties promise reduced post-treatment complications, whilst improving patient access to proton beam radiotherapy and reducing costs. However, accurate dosimetry at UHDR is extremely complicated. This work presents measurements performed with a primary-standard proton calorimeter and derivation of the required correction factors needed to determine absolute dose for FLASH proton beam radiotherapy with an uncertainty of 0.9% (1[Formula: see text]), in line with that of conventional treatments. The establishment of a primary standard for FLASH proton radiotherapy improves accuracy and consistency of the dose delivered and is crucial for the safe implementation of clinical trials, and beyond, for this new treatment modality.

Indexed as

NeoplasmsProton TherapyHumansProtonsRadiometryRadiotherapy DosageProtons

Identifiers

PMID36739297
PMCPMC9899251

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.